Risk of transmission of amyloid β pathology via transfused blood products
Summary
The article discusses the risk of transmitting amyloid β pathology, associated with Alzheimer's disease, through transfused blood products.
Similar Articles
FDA clears blood test to aid evaluation for Alzheimer's disease
The FDA has cleared the PrecivityAD2 blood test, developed from technology at WashU Medicine, to aid in Alzheimer's evaluation by detecting amyloid plaques with over 90% accuracy using mass spectrometry.
Copper transport drug restores memory and clears toxic Alzheimer's proteins
A drug that modulates copper transport shows promise in restoring memory and clearing toxic Alzheimer's-associated proteins in preclinical models.
There’s a New Link Between Gut Health and Alzheimer’s Disease
A study published in Nature Communications identifies imidazole propionate (ImP), a compound produced by gut bacteria, as a potential link between gut microbiome and Alzheimer's disease by weakening the blood-brain barrier and exacerbating amyloid beta and tau pathology.
Brain Vascular Age Prediction Using Cerebral Blood Flow Velocity and Machine Learning Algorithms
This paper uses machine learning models trained on transcranial Doppler features to predict brain vascular age, finding accelerated aging in subjects with brain diseases such as stroke and Alzheimer's.
@arcinstitute: The brain works hard to clear waste, and impairments are central to neurodegeneration. In @CellCellPress, Innovation In…
A new study in Cell maps how the brain clears waste, with implications for understanding neurodegeneration. Researchers tracked endogenous proteins to visualize waste removal pathways.